What are the N1 and N2 lymph‑node stations in the lung?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

N1 and N2 Lymph Node Stations in Lung Cancer

N1 stations are intrapulmonary and hilar lymph nodes (stations 10-14), while N2 stations are mediastinal lymph nodes (stations 1-9), with the boundary defined by the pleural reflection and specific anatomic landmarks.

Anatomic Definition

N1 Stations (Intrapulmonary and Hilar)

  • Station 10: Hilar nodes
  • Station 11: Interlobar nodes
  • Station 12: Lobar nodes
  • Station 13: Segmental nodes
  • Station 14: Subsegmental nodes

The N1 nodes can be further conceptualized as:

  • Peripheral zone: Stations 12-14 1
  • Hilar zone: Stations 10-11 1

N2 Stations (Mediastinal)

  • Station 1: Highest mediastinal nodes
  • Station 2R/2L: Upper paratracheal nodes
  • Station 3: Prevascular/retrotracheal nodes
  • Station 4R/4L: Lower paratracheal nodes
  • Station 5: Subaortic (aortopulmonary window) nodes
  • Station 6: Para-aortic nodes
  • Station 7: Subcarinal nodes
  • Station 8: Paraesophageal nodes
  • Station 9: Pulmonary ligament nodes

Critical Boundary Considerations

The Subcarinal Zone Controversy

A critical caveat exists regarding station 7 (subcarinal) nodes in lower lobe tumors. The IASLC lymph node map reclassified some nodes previously considered N1 (station 10) in the Naruke map to N2 (station 7). Research demonstrates that patients with subcarinal lymph node involvement have survival outcomes similar to N2 disease rather than N1 disease (5-year disease-free survival: N1 50.9% vs. subcarinal 33.3% vs. N2 24.4%, p=0.027 between N1 and subcarinal) 2. All lymph nodes in the subcarinal space should be considered N2 for prognostic purposes 2.

The Pleural Reflection Boundary

While the pleural reflection traditionally defines the boundary between N1 and N2, this anatomic landmark has prognostic limitations. Station 10 nodes (hilar nodes near the pleural reflection) show intermediate survival between clear N1 and N2 disease, though they remain classified as N1 3.

Clinical Implications for Lymph Node Evaluation

Current guidelines mandate systematic lymph node sampling or dissection as standard practice 4, 5. The American College of Surgeons Standard 5.8 requires that surgical pathology reports following curative-intent pulmonary resection must contain lymph nodes from at least three distinct mediastinal stations 5.

Lobe-Specific Patterns

Mediastinal lymph node drainage follows predictable patterns:

  • Superior stations (2-4 right, 5-6 left): Upper lobe cancers
  • Inferior stations (7-9): Lower lobe cancers 5

However, skip metastases to N2 stations without N1 involvement occur in 3-19% of clinical stage IA NSCLC 5, making comprehensive evaluation essential regardless of tumor location.

Prognostic Heterogeneity Within N1

The N1 category shows significant heterogeneity based on:

  • Single-station vs. multi-station involvement: Distinct survival differences exist 6, 7
  • Peripheral (stations 12-14) vs. hilar (stations 10-11) involvement: Different prognostic implications 1, 6

This heterogeneity underscores why adequate N1 assessment requires systematic evaluation of multiple stations, not just suspicious nodes 4, 5.

References

2
Research

Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2016

3
Research

Where is the boundary between N1 and N2 stations in lung cancer?

The Annals of thoracic surgery, 2000

Related Questions

What are the current guidelines for initiating and monitoring testosterone hormone replacement therapy in adult women with hypoactive sexual desire disorder or persistent menopausal symptoms?
When is non‑small cell lung carcinoma considered resectable versus non‑resectable?
Does naltrexone affect the white blood cell count and require routine monitoring?
What is the recommended treatment for Mycoplasma genitalium infection in an adult?
Does occupational or environmental exposure to perchloroethylene (PCE), trichloroethylene (TCE), vinyl chloride, or benzene increase the risk of peripheral artery disease?
How often can a stool softener such as docusate sodium be administered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.